Search - tctmd.com

Displaying 501 - 520 of 742

Sort: Relevancy | Date

Presentation TCT 2018

Pulmonary Artery Denervation II: RF Ablation Device and Latest Results

Presenter: Ori Ben-Yehuda, Jay S. Giri, Shao-Liang Chen

September 22, 2018

Presentation TCT 2018

A Vascular Compliance Enhancing Device for Treatment of Pulmonary Arterial Hypertension: Aria CV

Presenter: Louis A. Cannon, Juan F. Granada, John Scandurra

September 22, 2018

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

Presentation TCT 2018

Early Feasibility Studies for Device Evaluation

Presenter: Spencer B. King III, Bram D. Zuckerman, Andrew Farb

September 21, 2018

Presentation TCT 2018

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Presenter: Spencer B. King III, Bram D. Zuckerman, Chris Mullin, Roseann M White

September 21, 2018

Presentation TCT 2018

Practice Guideline Requirement for New Technology

Presenter: Spencer B. King III, Bram D. Zuckerman, Alice K. Jacobs

September 21, 2018

Presentation TCT 2018

CMS Requirement for Reimbursement for Innovation

Presenter: Spencer B. King III, Bram D. Zuckerman, Lori M Ashby

September 21, 2018

Presentation TCT 2018

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

Presenter: Spencer B. King III, Bram D. Zuckerman

September 21, 2018

Presentation TCT 2018

ISCTR Mission and Statement of Meeting Purpose

Presenter: Nabil Dib

September 21, 2018

News Daily News

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

Michael O'Riordan

September 18, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

News Daily News

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Caitlin E. Cox

June 25, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

Advertisement

Pulmonary Artery Denervation II: RF Ablation Device and Latest Results

A Vascular Compliance Enhancing Device for Treatment of Pulmonary Arterial Hypertension: Aria CV

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Early Feasibility Studies for Device Evaluation

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Practice Guideline Requirement for New Technology

CMS Requirement for Reimbursement for Innovation

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

ISCTR Mission and Statement of Meeting Purpose

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TCTMD’s Top 10 Most Popular Stories for August 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

New European Hypertension Guidelines Not in Harmony With US Guidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content